Почетна › Sitnoćelijski rak pluća › Mičigen
Kliničke studije za Sitnoćelijski rak pluća u državi Mičigen
26 studija za Sitnoćelijski rak pluća traži učesnike na lokacijama u državi Mičigen.
Gradovi u državi Mičigen
Zvanični tekst studije (na engleskom)
A Study of the c-Kit Specific Antibody-Drug Conjugate NN3201 for Advanced and/or Metastatic Solid Tumors Known to Express c-Kit
- University of Michigan Hospitals, Ann Arbor
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 13. 11. 2026. · NCT06805825A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors
- Barbara Ann Karmanos Cancer Center, Detroit
- START Midwest, Grand Rapids
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 13. 11. 2026. · NCT07488676DAREON ® -Lung-1: A Study in People With Advanced Small Cell Lung Cancer to Compare Obrixtamig Plus Atezolizumab, Carboplatin, and Etoposide Treatment With Standard Chemoimmunotherapy
- Veterans Affairs Ann Arbor Healthcare System, Ann Arbor
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 10. 11. 2026. · NCT07472517MOnaliZumab in Combination With durvAlumab (MEDI4736) for tRreatmenT of Small Cell Lung Cancer
- Karmanos Cancer Center (Wayne State University), Detroit
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 5. 11. 2026. · NCT05903092A Study of MGC026 in Participants With Advanced Solid Tumors
- START Midwest, Grand Rapids
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 28. 10. 2026. · NCT06242470A Study to Evaluate the Optimal Dose, Adverse Events and Change in Disease Activity of Intravenous ABBV-706 in Combination With Atezolizumab Versus Standard of Care as First-Line Treatment in Adult Participants With Previously Untreated Extensive Stage Small Cell Lung Cancer
- Henry Ford Hospital - Detroit /ID# 277218, Detroit
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 27. 10. 2026. · NCT07155174A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
- Research Site 129, Detroit
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 21. 10. 2026. · NCT05914116A Study of ZL-1310 Versus Investigator's Choice of Therapy in Participants With Relapsed Small Cell Lung Cancer (DLLEVATE)
- Henry Ford Health Cancer, Detroit
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 16. 10. 2026. · NCT07218146Study of Bevacizumab in Combination With Chemoimmunotherapy and Atezolizumab in Patients With Extensive Stage Small Cell Lung Cancer and Liver Metastases
- V.A. Ann Arbor Healthcare System, Ann Arbor
- University of Michigan, Ann Arbor
Тражи се учесникФаза 2
Сви узрасти · Оба пола · Ажурирано 8. 10. 2026. · NCT05588388AVA6103 in Subjects With Locally Advanced or Metastatic Selected Solid Tumors
- START Midwest, Grand Rapids
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 5. 10. 2026. · NCT07454642177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors
- BAMF Health, Grand Rapids
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 1. 10. 2026. · NCT07189871A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer
- Cancer And Hematology Centers Of Western Michigan - Grand Rapids /ID# 279955, Grand Rapids
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 23. 9. 2026. · NCT07365241Phase I Study of [225Ac]Ac-ETN029 in Patients With Advanced DLL3-expressing Solid Tumors
- Corewell Health William Beaum Hosp, Royal Oak
Тражи се учесникФаза 1
Узраст од 18 до 100 · Оба пола · Ажурирано 22. 9. 2026. · NCT07006727Phase 3 Trial of Tarlatamab (SC vs IV) in Extensive-Stage Small Cell Lung Cancer After Platinum Based First-line Chemotherapy (ES-SCLC)
- Cancer and Hematology Centers of Western Michigan, Grand Rapids
Тражи се учесникФаза 3
Узраст од 18 до 99 · Оба пола · Ажурирано 17. 9. 2026. · NCT07778316A Study to Assess the Safety and Tolerability of BMS-986525 Alone and in Combination Therapy in Participants With Relapsed/Refractory Small Cell Lung Cancer
- Karmanos Cancer Institute, Detroit
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 14. 9. 2026. · NCT07325136Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/ Refractory Small Cell Lung Cancer
- Henry Ford Cancer Institute, Detroit
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 19. 8. 2026. · NCT06922539A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
- Karmanos Cancer Institute, Detroit
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 11. 8. 2026. · NCT05592626A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer
- Henry Ford Health System, Detroit
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 6. 8. 2026. · NCT06203210Study of Sacituzumab Govitecan With Atezolizumab/Durvalumab as Maintenance Therapy for Extensive-Stage Small Cell Lung Cancer
- Henry Ford Cancer- Detroit, Detroit
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 28. 7. 2026. · NCT07339059A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors
- START Midwest, Grand Rapids
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 22. 7. 2026. · NCT06131840A Study of IDE849 in Patients With DLL3 Expressing Tumors Including Small Cell Lung Cancer
- START Midwest, Grand Rapids
- The Cancer and Hematology Centers, Grand Rapids
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 9. 7. 2026. · NCT07174583Subcutaneous Tarlatamab in Participants With Extensive Stage Small Cell Lung Cancer (DeLLphi-308)
- Trinity Health Saint Joseph Mercy Ann Arbor, Ann Arbor
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 26. 6. 2026. · NCT06598306Using Biomarker Tests to Select and Test New, Personalized Treatments for Extensive Stage Small Cell Lung Cancer, PRISM Study
- Trinity Health IHA Medical Group Hematology Oncology - Brighton, Brighton
- Trinity Health IHA Medical Group Hematology Oncology - Canton, Canton
- Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital, Chelsea
- и још 14
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 30. 3. 2026. · NCT06769126Biomarker Directed Trial of Temozolomide and Stenoparib in Relapsed SCLC
- VA Ann Arbor Healthcare System, Ann Arbor, MI, Ann Arbor
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 11. 3. 2026. · NCT06681220Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
- START Midwest, Grand Rapids
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 18. 2. 2026. · NCT07030257JAB-2485 Activity in Adult Patients With Advanced Solid Tumors
- Henry Ford Health System, Detroit
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 9. 1. 2026. · NCT05490472Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.